BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19212)

  • 1. The metabolism of p-methoxyamphetamine in dog and monkey. O-demethylation as a major route.
    Hubbard JW; Midha KK; Cooper JK
    Drug Metab Dispos; 1977; 5(4):329-34. PubMed ID: 19212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic O-demethylation of 3,4-dimethoxyamphetamine in vivo in dog and monkey.
    Midha KK; Bailey K; Cooper JK; Hubbard JW
    Xenobiotica; 1979 Aug; 9(8):485-90. PubMed ID: 117645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine.
    Kitchen I; Tremblay J; André J; Dring LG; Idle JR; Smith RL; Williams RT
    Xenobiotica; 1979 Jul; 9(7):397-404. PubMed ID: 582863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Methyldopamine, a key intermediate in the metabolic disposition of 3,4-methylenedioxyamphetamine in vivo in dog and monkey.
    Midha KK; Hubbard JW; Bailey K; Cooper JK
    Drug Metab Dispos; 1978; 6(6):623-30. PubMed ID: 33023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 3-O-methyl-alpha-methyldopamine as a urinary metabolite of 3,4-methylenedioxyamphetamine in dog and monkey.
    Midha KK; Cooper JK; By A; Ethier JC
    Drug Metab Dispos; 1977; 5(2):143-8. PubMed ID: 15806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-O-methyl-alpha-methyldopamine, a urinary metabolite of p-methoxyamphetamine in dog and monkey.
    Hubbard JW; Bailey K; Midha KK; Cooper JK
    Drug Metab Dispos; 1981; 9(3):250-4. PubMed ID: 6113935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption, excretion and disposition of cyclindole in laboratory animals and human volunteers.
    Benziger DP; Balfour K; Clemans S; Edelson J
    Drug Metab Dispos; 1977; 5(3):239-45. PubMed ID: 17521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans.
    Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF
    Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of methoxyphenamine in man and in monkey.
    Midha KK; Cooper JK; Mcgilveray IJ; Coutts RT; Dawe R
    Drug Metab Dispos; 1976; 4(6):568-76. PubMed ID: 11979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative metabolism of zolazepam in rat, dog and monkey.
    Baukema J; Okerholm RA; Glazko AJ
    Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):227-38. PubMed ID: 808840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
    Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD
    Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and disposition of sulfinalol in laboratory animals.
    Benziger DP; Fritz A; Edelson J
    Drug Metab Dispos; 1981; 9(6):493-8. PubMed ID: 6120804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism of 3-methoxyamphetamine in dog, monkey and man.
    Midha KK; Cooper JK; Bailey K; Hubbard JW
    Xenobiotica; 1981 Feb; 11(2):137-46. PubMed ID: 6894510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption and disposition of oxarbazole in man and laboratory animals.
    Benziger D; Dorrbecker S; Goehl T; Edelson J
    Drug Metab Dispos; 1978; 6(1):8-15. PubMed ID: 23278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of p-(cyclopropylcarbonyl)phenylacetic acid (SQ 20,650). Species Differences.
    Lan SJ; El-Hawey AM; Dean AV; Schreiber EC
    Drug Metab Dispos; 1975; 3(3):171-9. PubMed ID: 238816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin) in beagle dogs and rhesus monkeys.
    Janssen FW; Kirkman SK; Knowles JA; Ruelius HW
    Drug Metab Dispos; 1978; 6(4):465-75. PubMed ID: 28928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disposition of [14C]iprindole in man, dog, miniature swine, rhesus monkey and rat.
    Sisenwine SF; Tio CO; Ruelius HW
    Xenobiotica; 1979 Apr; 9(4):237-46. PubMed ID: 113942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of urinary metabolites of 8-methyl-8-azabicyclo-[3,2,1] octan-3-yl 3,5-dichlorobenzoate (MDL 72,222) in the dog and monkey.
    Gordon WP; Cheng H; Larsen DL; Ragner JA; Landmesser NG
    Drug Metab Dispos; 1992; 20(4):596-602. PubMed ID: 1356741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and biotransformation of quinpirole, a new D-2 dopamine agonist antihypertensive agent, in mice, rats, dogs, and monkeys.
    Whitaker NG; Lindstrom TD
    Drug Metab Dispos; 1987; 15(1):107-13. PubMed ID: 2881745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of ibopamine metabolites in rat and dog urine.
    Kuo GY; Hwang BY; Lynn RK
    Drug Metab Dispos; 1988; 16(6):793-8. PubMed ID: 2907455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.